Sadaf wassan biography of michael jackson
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas, Joshua Abbas, Kasim Abbas, Mustafa Abbas, Sadia Abbasi, Hakam Abbass, Alfie Abbott, Alison Abbott, Nabeel Abdallah, Ammar Abdelaziz, Ashraf Abdelaziz, Mohamed Abdelfattah, Bushra Abdelqader, Audrey Abdul, Basir Abdul, Siddiqui Abdul, Althaf Abdul Rasheed, Ajibode Abdulakeem, Rezan Abdul-Kadir, Abdullah Abdullah, Abdulfatahi Abdulmumeen, Rasheed Abdul-Raheem, Niyaz Abdulshukkoor, Kula Abdusamad, Yazeed Abed El Khaleq, Mai Abedalla, Abeer Abeer Ul Amna, Lynn Abel, Katrina Abernethy, Movin Abeywickrema, Chandra Abhinaya, Affyarsyah Abidin, Adebanke Aboaba, Abigail Aboagye-Odei, Christopher Aboah, Heba Aboelela, Hani Abo-Leyah, Karim Abouelela, Ahmed Abou-Haggar, Mahmoud Abouibrahim, Ahmed Abousamra, Mona Abouzaid, Miriam Abraham, Tizzy Abraham, Abraheem Abraheem, Judith Abrams, Rebecca Abrams, Hyacinth-John Abu, Ahmed Abu-Arafeh, Syed M Abubacker, Akata Abung, Yousuf Abusamra, Yaa Aceampong, Amaka Achara, Devikumar Acharya, Faustina Acheampong, Prince Acheampong, Sarah Acheampong, Janet Acheson, Shiella Achieng, Andres Acosta, Rebecca Acquah, Catherine Acton, Jacqueline Adabie-Ankrah, Paul Adair, Fiona Adam, Matthew Adam, Huzaifa Adamali, Marta Adamczyk, Carol Adams, Charlotte Adams, Daniel Adams, Kate Adams, Laura Adams, Nikkita Adams, Richard Adams, Tim Adams, Laura Adamu-Ikeme, Krishma Adatia, Kirsty Adcock, Lawrence Addai-Boampo
The NIHR invests significantly in centres of excellence, collaborations, services and facilities to support research in England. Collectively these form the NIHR research infrastructure. We award more than £606 million of funding per year to world leading NHS organisations and academic institutions with a proven, international track record in health and care research. The funding awards are significant multi-million-pound investments. Our significant and sustained research infrastructure funding supports the country’s leading experts in world-class research organisations.
NIHR research infrastructure funding provides a platform to enable research, acting as a targeted and strategic investment to create an environment where early stage and applied research can thrive. Our research infrastructure provides research expertise, specialist facilities, a research delivery workforce and support services which all help to support and deliver the research we fund, and research funded by others. Research funded by UK Research and Innovation (UKRI), medical research charities, the life sciences industry (biopharmaceuticals, medtech, genomics, diagnostics and digital health), and other relevant industries all benefit from the network of services and support that we provide.
This is an NIHR research infrastructure dataset and excludes the Research Delivery Network (RDN). The dataset is accurate as of the end of the 2023/24 financial year and is updated annually. It shows studies supported by the Applied Health and Social Care Research Collaborations (ARCs), Biomedical Research Centres (BRCs), Clinical Research Facilities (CRFs), Medtech and In vitro diagnostics Co-operatives (MICs) and Patient Safety Research Collaborations (PSRCs). Projects appear as duplicates if they have been reported by multiple Infrastructure Centres in multiple years. Using this dataset, users can search for projects that were supported by the abovementioned NIHR Infrastructure schemes by financial Group by: Author | Type Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | U | V | W | X | Y | Z Number of items: 321. .A
Agbuduwe, Charles; Iqbal, Gulnaz; Cairns, David A; Menzies, Tom; Dunn, Janet; Gregory, Walter Martin; Kaiser, Martin F; ... Basu, Supratik; + view allAgbuduwe, Charles; Iqbal, Gulnaz; Cairns, David A; Menzies, Tom; Dunn, Janet; Gregory, Walter Martin; Kaiser, Martin F; Owen, Roger G; Pawlyn, Charlotte; Child, J Anthony; Davies, Faith E; Morgan, Gareth J; Jackson, Graham H; Drayson, Mark T; Basu, Supratik; - view fewer (2022) Clinical Characteristics and Outcomes of IgD Myeloma: Experience across UK National Trials.Blood Advances10.1182/bloodadvances.2022007608. (In press). Agerbæk, M; Bang-Christensen, SR; Yang, MH; Clausen, TM; Pereira, MA; Sharma, S; Ditlev, SB; ... Salanti, A; + view allAgerbæk, M; Bang-Christensen, SR; Yang, MH; Clausen, TM; Pereira, MA; Sharma, S; Ditlev, SB; Nielsen, MA; Choudhary, S; Gustavsson, T; Sorensen, PH; Meyer, T; Propper, D; Shamash, J; Theander, TG; Aicher, A; Daugaard, M; Heeschen, C; Salanti, A; - view fewer (2022) Author Correction to: The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner (Nature Communications, (2018), 9, 1, (3279), 10.1038/s41467-018-05793-2).Nature Communications , 13 (1) , Article 3285. 10.1038/s41467-022-29351-z. Aggarwal, D; Page, AJ; Schaefer, U; Savva, GM; Myers, R; Volz, E; Ellaby, N; ... Harrison, EM; + view allAggarwal, D; Page, AJ; Schaefer, U; Savva, GM; Myers, R; Volz, E; Ellaby, N; Platt, S; Groves, N; Gallagher, E; Tumelty, NM; Le Viet, T; Hughes, GJ; Chen, C; Turner, C; Logan, S; Harrison, A; The COVID-19 Genomics UK (COG-UK) Consortium; Peacock, SJ; Chand, M; Harrison, EM; - view fewer (2022) Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission.Nature Communications , 13 , Article 1012. 10.1038/s41467-022-28371-z.